HYPR — Hyperfine, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1833769 ·
Last close
$1.66
Market Cap
$139.80M
52W High
$1.93
52W Low
$1.01
ADV30
717,484
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,903,000 | 1,979,000 | -8,558,000 | -8,623,000 | 60,339,000 | 40,778,000 | 25,978,000 |
| Dec 2025 | 5,293,000 | 2,694,000 | -7,668,000 | -5,912,000 | 55,262,000 | 35,085,000 | 14,257,000 |
| Sep 2025 | 3,437,000 | 1,848,000 | -8,920,000 | -11,019,000 | 41,511,000 | 21,564,000 | 14,639,000 |
| Jun 2025 | 2,696,000 | 1,328,000 | -9,595,000 | -9,225,000 | 45,234,000 | 25,420,000 | 10,108,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-27,948,000
Investing CF
$-1,185,000
Financing CF
$27,502,000
CapEx
$-1,185,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.44
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-330,016,000
Inventory
$7,090,000
Receivables
$6,522,000
ST Investments
—
EBIT TTM
$-37,085,000
Pretax Income TTM
$-35,574,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,329,000
EBITDA
$-33,606,000
Free Cash Flow
$-16,274,000
Enterprise Value
$120,257,800
Total Cash
$40,778,000
Total Debt
$13,123,000
Shares Out
84,215,048
Trailing EPS
$-0.40
Book Value
$0.35
ROE
-89.8%
ROA
-38.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,563,000 | -37,085,000 | -35,574,000 | 55,262,000 | 14,257,000 | — | -27,948,000 |
| Dec 2024 | 12,890,000 | -43,224,000 | -40,720,000 | 58,901,000 | 9,861,000 | — | -38,767,000 |
| Dec 2023 | 11,032,000 | -48,115,000 | -44,238,000 | 94,199,000 | 9,800,000 | — | -41,809,000 |
| Dec 2022 | 6,814,000 | -73,874,000 | -73,164,000 | 134,051,000 | 10,329,000 | — | -72,339,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Max Pain — expiry 2026-07-17
max pain strike: $2.50 · spot: $1.66 · call oi: 1,122 · put oi: 59
Expected Move to 2026-07-17:
±$1.25
(75.30%) —
implied range
$0.41 –
$2.91
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNWV | SANUWAVE Health, Inc. | $139.82M | $16.26 | — |
| NNOX | Nano-X Imaging Ltd. | $137.79M | $1.98 | — |
| GUTS | FRACTYL HEALTH, INC. | $145.61M | $0.92 | — |
| STEX | Streamex Corp. | $147.03M | $1.41 | — |
| RCEL | AVITA Medical, Inc. | $130.80M | $4.25 | — |
News headlines (Yahoo Finance, 1h cache)
Hyperfine shares rise after expected Russell index addition (HYPR)
2026-05-26 12:57 · Yahoo
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
2026-05-26 12:15 · Yahoo
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
2026-05-22 12:15 · Yahoo
Hyperfine Inc (HYPR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ...
2026-05-13 05:01 · Yahoo
Hyperfine Q1 Earnings Call Highlights
2026-05-13 00:25 · Yahoo
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
2026-05-12 21:40 · Yahoo
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
2026-05-12 20:05 · Yahoo
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates
2026-05-11 22:05 · Yahoo
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
2026-05-08 12:25 · Yahoo
BTIG Initiates Coverage of Hyperfine, Inc. (HYPR) With a Bullish Outlook
2026-05-07 17:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.